160 related articles for article (PubMed ID: 38233377)
21. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
22. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
[TBL] [Abstract][Full Text] [Related]
23. Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG.
Zhao H; Li N; Pang Y; Zhao J; Wu X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313950
[TBL] [Abstract][Full Text] [Related]
24. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
He J; Xie G; Tong J; Peng Y; Huang H; Li J; Wang N; Liang H
Cell Biochem Biophys; 2014 Nov; 70(2):1343-50. PubMed ID: 24898807
[TBL] [Abstract][Full Text] [Related]
26. DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.
Kang KA; Ryu YS; Piao MJ; Shilnikova K; Kang HK; Yi JM; Boulanger M; Paolillo R; Bossis G; Yoon SY; Kim SB; Hyun JW
Redox Biol; 2018 Jul; 17():224-235. PubMed ID: 29715584
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.
Chen S; Yue T; Huang Z; Zhu J; Bu D; Wang X; Pan Y; Liu Y; Wang P
Cancer Lett; 2019 Dec; 466():49-60. PubMed ID: 31542354
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of c-fos in resistant cell line TU177/VCR of larynx squamous cell carcinoma].
Li GD; Hu XL; Xing JF; Shi RY; Li X; Li JF; Li TL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):281-285. PubMed ID: 29747253
[No Abstract] [Full Text] [Related]
29. Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation.
Fu Y; Yang G; Zhu F; Peng C; Li W; Li H; Kim HG; Bode AM; Dong Z; Dong Z
Cell Death Dis; 2014 Jan; 5(1):e983. PubMed ID: 24407236
[TBL] [Abstract][Full Text] [Related]
30. Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis.
Wu H; Du J; Li C; Li H; Guo H; Li Z
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408903
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J
Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613
[TBL] [Abstract][Full Text] [Related]
32. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
[TBL] [Abstract][Full Text] [Related]
33. miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Luo S; Xie J
Oncol Rep; 2017 Jan; 37(1):123-130. PubMed ID: 27878272
[TBL] [Abstract][Full Text] [Related]
34. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
35. Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells.
Kim K; Yeo SG
Tumori; 2014; 100(6):e230-5. PubMed ID: 25688504
[TBL] [Abstract][Full Text] [Related]
36. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
[TBL] [Abstract][Full Text] [Related]
37. Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer.
Gu XY; Jiang Y; Li MQ; Han P; Liu YL; Cui BB
Aging (Albany NY); 2020 Jan; 12(1):156-177. PubMed ID: 31896739
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
39. PCDH7 knockdown potentiates colon cancer cells to chemotherapy via inducing ferroptosis and changes in autophagy through restraining MEK1/2/ERK/c-Fos axis.
Liu Z; Xu Y; Liu X; Wang B
Biochem Cell Biol; 2022 Dec; 100(6):445-457. PubMed ID: 35926236
[TBL] [Abstract][Full Text] [Related]
40. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.
Kurokawa K; Tanahashi T; Iima T; Yamamoto Y; Akaike Y; Nishida K; Masuda K; Kuwano Y; Murakami Y; Fukushima M; Rokutan K
J Gastroenterol; 2012 Aug; 47(8):883-95. PubMed ID: 22382630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
